Natural Capsules Ltd
NSE: NATCAPSUQ BSE: 524654
Incorporated in 1993, Natural Capsules manufactures Capsules and Steroidal APIs and their Intermediates and Derivatives[1]
₹153
52W: ₹136 — ₹296
PE 19.1 · Book ₹167 · -8% vs bookMarket Cap₹159 Cr
Stock P/E19.1Price to Earnings
ROCE7.39%Return on Capital
ROE4.5%Return on Equity
Div. Yield0%Face Value ₹10
Strengths
- +Stock is trading at 0.90 times its book value
Weaknesses
- −Though the company is reporting repeated profits, it is not paying out dividend
- −Company has a low return on equity of 8.85% over last 3 years.
- −Contingent liabilities of Rs.70.8 Cr.
- −Earnings include an other income of Rs.7.08 Cr.
- −Dividend payout has been low at 1.61% of profits over last 3 years
- −Promoter holding has decreased over last 3 years: -5.52%
Shareholding Pattern
Promoters51.04%
FIIs0%
DIIs0%
Public48.96%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 56.57% | 51.59%▼5.0 | 51.13%▼0.5 | 51.21%▲0.1 | 51.26%▲0.0 | 51.26% | 51.26% | 51.04%▼0.2 |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.18% | 0%▼0.2 | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 43.25% | 48.39%▲5.1 | 48.86%▲0.5 | 48.8%▼0.1 | 48.75%▼0.0 | 48.73%▼0.0 | 48.74%▲0.0 | 48.96%▲0.2 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 37.52 | 38.38 | 40.2 | 39.14 | 41.03 | 43.41 | 44.36 | 44.24 | 44.58 | 34.15 |
| Expenses | 32.28 | 33.44 | 35.7 | 34.41 | 36.09 | 38.82 | 39.32 | 39.1 | 39.14 | 32.26 |
| Operating Profit | 5.24 | 4.94 | 4.5 | 4.73 | 4.94 | 4.59 | 5.04 | 5.14 | 5.44 | 1.89 |
| OPM % | 13.97% | 12.87% | 11.19% | 12.08% | 12.04% | 10.57% | 11.36% | 11.62% | 12.2% | 5.53% |
| Net Profit | 1.97 | 1.7 | 1.69 | 1.46 | 0.92 | 1.7 | 2.63 | 2.52 | 2.81 | 0.36 |
| EPS ₹ | 2.12 | 1.82 | 1.81 | 1.56 | 0.9 | 1.64 | 2.54 | 2.44 | 2.72 | 0.35 |
AI Insights
Revenue Trend
TTM revenue at ₹167Cr, down 0.6% YoY. OPM at 10%.
Debt Position
Borrowings at ₹59Cr. Debt-to-equity ratio: 0.36x. Healthy balance sheet.
Institutional Flow
DIIs: 0% (-1.31pp change). FIIs: 0% (+0.00pp change). Promoters hold 51.04%.
Margin & Efficiency
ROCE declining from 18% (Mar 2014) to 7% (Mar 2025). Working capital days: 40.
Valuation
PE 19.1x with 7.39% ROCE. Price is -8% above book value of ₹167. Dividend yield: 0%.
Recent Announcements
- Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 7 May - FY 2025-26 SEBI disclosure: Natural Capsules not a large corporate; incremental borrowing nil.
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Natural Capsules says it is not a Large Corporate; outstanding borrowing was 23.38 crore on March 31, 2026.
- Announcement under Regulation 30 (LODR)-Cessation 25 Apr - Pranjal Deshmukh resigned as Company Secretary and Compliance Officer, effective 25 April 2026.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 24 Apr - Newspaper publication regarding second 100 days campaign-" Saksham Niveshak"
- Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015, Intimation Regarding Second 100 Days Campaign - Saksham Niveshak. 23 Apr - Company launches 100-day campaign to help shareholders claim unpaid dividends and update KYC details.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse